{"id":"W2754043363","doi":"10.1136/annrheumdis-2017-eular.2445","title":"AB0794 Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: results from two phase 3 studies","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Zynerba Pharmaceuticals; Dermira; Genentech; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Ankylosing spondylitis; Janus kinase inhibitor; Adalimumab; Placebo; Internal medicine; Visual analogue scale; Psoriasis; Arthritis; Dermatology; Surgery; Rheumatoid arthritis; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002740814,0.001304751,0.002643395,0.0004374507,0.000493099,0.001249103,0.0007332342,0.001399927,0.00235615],"category_scores_gemma":[0.002150451,0.0004048567,0.004613991,0.0006299402,0.0007371005,0.001042308,0.0003410672,0.003323897,0.0004274703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008030166,"about_ca_system_score_gemma":0.00103784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001171623,"about_ca_topic_score_gemma":0.002734149,"domain_scores_codex":[0.9989349,0.0005144392,0.00008981196,0.0001383135,0.0001642781,0.0001582358],"domain_scores_gemma":[0.9982219,0.0007263038,0.0004610302,0.0001348528,0.0001675886,0.000288332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7564981,0.01708022,0.01838957,0.002359201,0.01698712,0.0002769011,0.000243114,0.001549604,0.01135672,0.0001946227,0.003093481,0.1719712],"study_design_scores_gemma":[0.6473195,0.2292902,0.1012223,0.0002937203,0.01303498,0.0005781091,0.0001960117,0.001077027,0.002400192,0.0004103912,0.004065524,0.000112091],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976938,0.01816547,0.0002588263,0.0005916683,0.0001924616,0.0004328334,0.001348269,0.00005928559,0.002013129],"genre_scores_gemma":[0.9882017,0.00714031,0.0006264762,0.0009555529,0.0002960018,0.0004268509,0.001677511,0.0000169082,0.0006586854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002740814,"threshold_uncertainty_score":0.01449502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04343408846701979,"score_gpt":0.3805636743739268,"score_spread":0.337129585906907,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}